Endocrine-Related Cancer
Journal of Endocrinology (JOE)
Journal of Molecular Endocrinology (JME)
Endocrine-Related Cancer (ERC)
BioScientifica
Skip to main page content
HOME
ERC
About
Accepted MSS
New Articles
Free Reviews
Best Metabolism Booster
Best Testosterone Booster
Best Melatonin Supplement
RSS
Submit
HELP
Contact
Search for Keyword:
GO
Advanced Search
User Name
Password
Sign In
CrossRef Cited-by Linking Search Results
This Article:
Regular papers
:
Nicole L Moore
,
Grant Buchanan
,
Jonathan M Harris
,
Luke A Selth
,
Tina Bianco-Miotto
,
Adrienne R Hanson
,
Stephen N Birrell
,
Lisa M Butler
,
Theresa E Hickey
,
and
Wayne D Tilley
An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity
Endocr Relat Cancer
19
(
4
)
599
-
613
, doi:
10.1530/ERC-12-0065
first published on
20 June 2012
Abstract
Full Text
Full Text (PDF)
Figures Only
Supplementary Data
has not yet been cited by articles in journals that are participating in CrossRef Cited-by Linking.
New Articles: issue in progress
October 2014, 21 (5)
Alert me to new issues of
Endocrine-Related Cancer
About BioScientifica journals
About SfE journals
About ESE journals
About this journal
Editorial board
For authors
Ethical guidelines
Bioscientifica Open Access policy
For readers
Most cited
/
most read
Recommend this journal to your library
Permissions information
For libraries
Sales and corporate services
Terms and conditions
Journals owned by the Society for Endocrinology
Journal of Endocrinology (JOE)
Journal of Molecular Endocrinology (JME)
Endocrine-Related Cancer (ERC)
Society for Endocrinology
European Society of Endocrinology
Most
Viewed
Bone metastases from differentiated thyroid carcinoma
Current and emerging biomarkers in breast cancer: prognosis and prediction
The association between serum TSH concentration and thyroid cancer
Diabetes and cancer
Rare metastases of differentiated thyroid carcinoma: pictorial review
» View all Most Viewed articles
Cited
Fibroblast growth factors, their receptors and signaling
The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification
mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer
BRAF mutation in thyroid cancer
Discovery of a novel Raf kinase inhibitor
» View all Most Cited articles